Testing a new medication for rheumatoid arthritis

This early-stage trial is testing a new medication called BMS-986454 to see if it is safe and how your body processes it in people with rheumatoid arthritis. Researchers want to understand how the medication works and whether it helps reduce joint swelling and inflammation. This is one of the first studies of this medication in humans.

Many people with rheumatoid arthritis don't respond well enough to standard treatments like methotrexate. This trial is exploring whether this new treatment might offer another option for people whose current medications aren't controlling their disease well enough.